脓毒症心肌病发病机制及其应用的研究进展  

Research progress of pathogenesis and clinical application in septic cardiomyopathy

作　　者：刘慧敏 高志杰 周荣[2] LIU Huimin;GAO Zhijie;ZHOU Rong

机构地区：[1]兰州大学第一临床医学院,兰州730000 [2]兰州大学第一医院急诊科

出　　处：《临床急诊杂志》2021年第6期437-440,共4页Journal of Clinical Emergency

摘　　要：脓毒症定义的核心是感染导致的器官功能障碍,脓毒症心肌病(septic cardiomyopathy,SCM)是脓毒症相关的心血管衰竭的并发症,也是脓毒症器官功能障碍的重要原因。但目前脓毒症心肌病的发病机制仍尚未完全阐明,仍有几个问题亟待我们去解决。例如有哪些机制或者因素引起了脓毒症心肌病的发生?我们应该如何科学的治疗脓毒症心肌病患者?本文综述了目前有关脓毒症心肌病所涉及的病理生理过程.Sepsis is defined as a life-threatening organ dysfunction due to a dysregulated immune response to an infection. It is receiving more and more attention. Because it is a significant cause of mortality in clinics. Septic cardiomyopathy is an important contributor to organ dysfunction in sepsis. Until now, the mechanism has not been fully elucidated. This review provides some most common underlying mechanisms of septic cardiomyopathy, and briefly outlines current therapeutic strategies and novel treatment options based on these mechanisms.

关 键 词：脓毒症心肌病 发病机制 临床应用 治疗 

分 类 号：R459.7[医药卫生—急诊医学]